1436851-33-0

Basic information

• Product Name: C₄₀H₄₃ClN₁₀O₉S
• Synonyms: C₄₀H₄₃ClN₁₀O₉S
• CAS NO: 1436851-33-0
• Molecular Weight: 875.362
• Mol File: 1436851-33-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₄₀H₄₃ClN₁₀O₉S(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₀H₄₃ClN₁₀O₉S(1436851-33-0)
• EPA Substance Registry System: C₄₀H₄₃ClN₁₀O₉S(1436851-33-0)

Safety Data

• Hazardous Substances Data: 1436851-33-0(Hazardous Substances Data)

Upstream product

• 1436851-27-2 ethyl 2-[4-(4-amino-3-methoxyphenyl)piperazin-1-yl]acetate 
• 1436851-26-1 ethyl 2-(4-(3-methoxy-4-nitrophenyl)piperazin-1-yl)acetate 
• 1245575-37-4 3-(phenylsulfonyl)-4-(2-(piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide 
• 1436851-29-4 2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)-amino)-3-methoxyphenyl)piperazin-1-yl)acetic acid 
• 448-19-1 4-fluoro-2-methoxy-1-nitrobenzene 
• 1436851-28-3 C₂₈H₃₁ClN₆O₅ 
• 1374641-75-4 N-(3-((2,5-dichloropyrimidin-4-yl)oxy)phenyl)acrylamide 
• 1374641-74-3 3-((2,5-dichloropyrimidin-4-yl)oxy)aniline 
• 76661-24-0 2,5-dichloro-4-(3-nitrophenoxy)pyrimidine 
• 554-84-7 meta-nitrophenol 

Relevant articles and documents

Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer

A series of hybrids (12a-k) from (phenylsulfonyl)furoxan and anilinopyrimidine were synthesized and biologically evaluated as epidermal growth factor receptor (EGFR) inhibitors for intervention of non-small-cell lung cancer (NSCLC). Compound 12k exhibited